MDx Finding Traction in European Labs, Leerink Swann Says
July 18, 2012
MDx Finding Traction in European Labs, Leerink Swann Says
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Gen-Probe to Serve as 'Cornerstone' of Hologic's MDx Franchise, Primarily Through STD Test Offerings
May 3, 2012 / PCR Insider - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider - Dx Focus: Cepheid Xpert CT/NG; Qiagen Therascreen EGFR; Luminex xTag GPP; Hologic Aptima Trichomonas
January 17, 2013 / PCR Insider - PerkinElmer Buys Shanghai Haoyuan for Near-Term Blood Screening Play, Longer Term MDx Initiative
November 15, 2012 / PCR Insider